Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
J Biol Chem ; 286(17): 15116-25, 2011 Apr 29.
Article in English | MEDLINE | ID: mdl-21357625

ABSTRACT

G protein-coupled receptor (GPCR) pathways control glucose and fatty acid metabolism and the onset of obesity and diabetes. Regulators of G protein signaling (RGS) are GTPase-activating proteins (GAPs) for G(i) and G(q) α-subunits that control the intensity and duration of GPCR signaling. Herein we determined the role of Rgs16 in GPCR regulation of liver metabolism. Rgs16 is expressed during the last few hours of the daily fast in periportal hepatocytes, the oxygen-rich zone of the liver where lipolysis and gluconeogenesis predominate. Rgs16 knock-out mice had elevated expression of fatty acid oxidation genes in liver, higher rates of fatty acid oxidation in liver extracts, and higher plasma ß-ketone levels compared with wild type mice. By contrast, transgenic mice that overexpressed RGS16 protein specifically in liver exhibited reciprocal phenotypes as well as low blood glucose levels compared with wild type littermates and fatty liver after overnight fasting. The transcription factor carbohydrate response element-binding protein (ChREBP), which induces fatty acid synthesis genes in response to high carbohydrate feeding, was unexpectedly required during fasting for maximal Rgs16 transcription in liver and in cultured primary hepatocytes during gluconeogenesis. Thus, RGS16 provides a signaling mechanism for glucose production to inhibit GPCR-stimulated fatty acid oxidation in hepatocytes.


Subject(s)
Fatty Acids/metabolism , Nuclear Proteins/physiology , RGS Proteins/physiology , Transcription Factors/physiology , Animals , Basic Helix-Loop-Helix Leucine Zipper Transcription Factors , Fatty Acids/biosynthesis , Fatty Acids/genetics , Gluconeogenesis , Glucose/biosynthesis , Glucose/physiology , Hepatocytes/metabolism , Liver/metabolism , Mice , Mice, Knockout , Mice, Transgenic , Oxidation-Reduction , Receptors, G-Protein-Coupled/metabolism , Transcription, Genetic
2.
Cell Metab ; 9(2): 165-76, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19187773

ABSTRACT

Mutations in 1-acylglycerol-3-phosphate-O-acyltransferase 2 (AGPAT2) cause congenital generalized lipodystrophy. To understand the molecular mechanisms underlying the metabolic complications associated with AGPAT2 deficiency, Agpat2 null mice were generated. Agpat2(-/-) mice develop severe lipodystrophy affecting both white and brown adipose tissue, extreme insulin resistance, diabetes, and hepatic steatosis. The expression of lipogenic genes and rates of de novo fatty acid biosynthesis were increased approximately 4-fold in Agpat2(-/-) mouse livers. The mRNA and protein levels of monoacylglycerol acyltransferase isoform 1 were markedly increased in the livers of Agpat2(-/-) mice, suggesting that the alternative monoacylglycerol pathway for triglyceride biosynthesis is activated in the absence of AGPAT2. Feeding a fat-free diet reduced liver triglycerides by approximately 50% in Agpat2(-/-) mice. These observations suggest that both dietary fat and hepatic triglyceride biosynthesis via a monoacylglycerol pathway may contribute to hepatic steatosis in Agpat2(-/-) mice.


Subject(s)
1-Acylglycerol-3-Phosphate O-Acyltransferase/metabolism , Fatty Liver/metabolism , Insulin Resistance/genetics , Lipodystrophy, Congenital Generalized/metabolism , 1-Acylglycerol-3-Phosphate O-Acyltransferase/genetics , Adipose Tissue/metabolism , Animals , Energy Metabolism , Lipodystrophy, Congenital Generalized/genetics , Mice , Mice, Knockout , Models, Animal , Triglycerides/biosynthesis
3.
Am J Physiol Gastrointest Liver Physiol ; 297(5): G1009-18, 2009 Nov.
Article in English | MEDLINE | ID: mdl-20501432

ABSTRACT

In the liver, adenosine triphosphate (ATP) is an extracellular signaling molecule that is released into bile and stimulates a biliary epithelial cell secretory response via engagement of apical P2 receptors. The molecular identities of the ion channels involved in ATP-mediated secretory responses have not been fully identified. Intermediate-conductance Ca(2+)-activated K(+) channels (IK) have been identified in biliary epithelium, but functional data are lacking. The aim of these studies therefore was to determine the location, function, and regulation of IK channels in biliary epithelial cells and to determine their potential contribution to ATP-stimulated secretion. Expression of IK-1 mRNA was found in both human Mz-Cha-1 biliary cells and polarized normal rat cholangiocyte (NRC) monolayers, and immunostaining revealed membrane localization with a predominant basolateral signal. In single Mz-Cha-1 cells, exposure to ATP activated K(+) currents, increasing current density from 1.6 +/- 0.1 to 7.6 +/- 0.8 pA/pF. Currents were dependent on intracellular Ca(2+) and sensitive to clotrimazole and TRAM-34 (specific IK channel inhibitors). Single-channel recording demonstrated that clotrimazole-sensitive K(+) currents had a unitary conductance of 46.2 +/- 1.5 pS, consistent with IK channels. In separate studies, 1-EBIO (an IK activator) stimulated K(+) currents in single cells that were inhibited by clotrimazole. In polarized NRC monolayers, ATP significantly increased transepithelial secretion which was inhibited by clotrimazole. Lastly, ATP-stimulated K(+) currents were inhibited by the P2Y receptor antagonist suramin and by the inositol 1,4,5-triphosphate (IP3) receptor inhibitor 2-APB. Together these studies demonstrate that IK channels are present in biliary epithelial cells and contribute to ATP-stimulated secretion through a P2Y-IP3 receptor pathway.


Subject(s)
Biliary Tract/physiology , Epithelial Cells/physiology , Intermediate-Conductance Calcium-Activated Potassium Channels/physiology , Adenosine Triphosphate/pharmacology , Animals , Apamin/pharmacology , Barium/pharmacology , Benzimidazoles/pharmacology , Biliary Tract/cytology , Buffers , Cell Line, Tumor , Cell Membrane/metabolism , Cells, Cultured , Chelating Agents/pharmacology , Clotrimazole/pharmacology , Egtazic Acid/analogs & derivatives , Egtazic Acid/pharmacology , Electrophysiological Phenomena , Epithelial Cells/drug effects , Gene Expression/genetics , Humans , Inositol 1,4,5-Trisphosphate Receptors/antagonists & inhibitors , Intermediate-Conductance Calcium-Activated Potassium Channels/agonists , Intermediate-Conductance Calcium-Activated Potassium Channels/antagonists & inhibitors , Models, Biological , Patch-Clamp Techniques , Purinergic P2 Receptor Antagonists , Pyrazoles/pharmacology , Rats , Signal Transduction/drug effects , Signal Transduction/physiology , Suramin/pharmacology
4.
Exp Cell Res ; 314(10): 2100-9, 2008 Jun 10.
Article in English | MEDLINE | ID: mdl-18405894

ABSTRACT

5'-AMP-activated kinase (AMPK) plays a key role in the regulation of cellular lipid metabolism. The contribution of vesicular exocytosis to this regulation is not known. Accordingly, we studied the effects of AMPK on exocytosis and intracellular lipid content in a model liver cell line. Activation of AMPK by metformin or 5-aminoimidazole-4-carboxamide-1-beta-d-ribofuranoside (AICAR) increased the rates of constitutive exocytosis by about 2-fold. Stimulation of exocytosis by AMPK occurred within minutes, and persisted after overnight exposure to metformin or AICAR. Activation of AMPK also increased the amount of triacylglycerol (TG) and apolipoprotein B (apoB) secreted from lipid-loaded cells. These effects were accompanied by a decrease in the intracellular lipid content indicating that exocytosis of lipoproteins was involved in these lipid-lowering effects. While AMPK increased the rates of fatty acid oxidation (FAO), the lipid-lowering effects were quantitatively significant even after inhibition of FAO with R-etomoxir. These results suggest that hepatic AMPK stimulates constitutive exocytosis of lipoproteins, which may function in parallel with FAO to regulate intracellular lipid content.


Subject(s)
Apolipoproteins B/metabolism , Exocytosis/physiology , Hepatocytes/metabolism , Multienzyme Complexes/metabolism , Protein Serine-Threonine Kinases/metabolism , Triglycerides/metabolism , AMP-Activated Protein Kinases , Aminoimidazole Carboxamide/analogs & derivatives , Aminoimidazole Carboxamide/pharmacology , Amiodarone/pharmacology , Animals , Cell Line , Enzyme Inhibitors/pharmacology , Epoxy Compounds/pharmacology , Exocytosis/drug effects , Fatty Acids/chemistry , Fatty Acids/metabolism , Hepatocytes/cytology , Humans , Hypoglycemic Agents/pharmacology , Lipid Metabolism , Lovastatin/analogs & derivatives , Lovastatin/metabolism , Metformin/pharmacology , Multienzyme Complexes/genetics , Oxidation-Reduction , Patch-Clamp Techniques , Protein Serine-Threonine Kinases/genetics , Rats , Ribonucleotides/pharmacology , Sterol Regulatory Element Binding Protein 1/genetics , Sterol Regulatory Element Binding Protein 1/metabolism , Triglycerides/chemistry
5.
Cell Metab ; 5(6): 415-25, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17550777

ABSTRACT

Peroxisome proliferator-activated receptor alpha (PPARalpha) regulates the utilization of fat as an energy source during starvation and is the molecular target for the fibrate dyslipidemia drugs. Here, we identify the endocrine hormone fibroblast growth factor 21 (FGF21) as a mediator of the pleiotropic actions of PPARalpha. FGF21 is induced directly by PPARalpha in liver in response to fasting and PPARalpha agonists. FGF21 in turn stimulates lipolysis in white adipose tissue and ketogenesis in liver. FGF21 also reduces physical activity and promotes torpor, a short-term hibernation-like state of regulated hypothermia that conserves energy. These findings demonstrate an unexpected role for the PPARalpha-FGF21 endocrine signaling pathway in regulating diverse metabolic and behavioral aspects of the adaptive response to starvation.


Subject(s)
Fasting/physiology , Fibroblast Growth Factors/physiology , Hepatocytes/metabolism , Liver/metabolism , PPAR alpha/metabolism , Adenoviridae/genetics , Adipose Tissue/metabolism , Animals , Cells, Cultured , Chromatin Immunoprecipitation , Female , Humans , Immunoblotting , Lipolysis/physiology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Plasmids , RNA, Messenger/genetics , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction/physiology , Transfection
6.
JOP ; 6(4): 303-15, 2005 Jul 08.
Article in English | MEDLINE | ID: mdl-16006680

ABSTRACT

Genetic predisposition and environmental influences insidiously converge to cause glucose intolerance and hyperglycemia. Beta-cell compensates by secreting more insulin and when it fails, overt diabetes mellitus ensues. The need to understand the mechanisms involved in insulin secretion cannot be stressed enough. Phosphorylation of proteins plays an important role in regulating insulin secretion. In order to understand how a particular cellular process is regulated by protein phosphorylation the nature of the protein kinases and protein phosphatases involved and the mechanisms that determine when and where these enzymes are active should be investigated. While the actions of protein kinases have been intensely studied within the beta-cell, less emphasis has been placed on protein phosphatases even though they play an important regulatory role. This review focuses on the importance of protein phosphatase 2A in insulin secretion. Most of the present knowledge on protein phosphatase 2A originates from protein phosphatase inhibitor studies on islets and beta-cell lines. The ability of protein phosphatase 2A to change its activity in the presence of glucose and inhibitors provides clues to its role in regulating insulin secretion. An aggressive approach to elucidate the substrates and mechanisms of action of protein phosphatases is crucial to the understanding of phosphorylation events within the beta-cell. Characterizing protein phosphatase 2A within the beta-cell will certainly help us in understanding the mechanisms involved in insulin secretion and provide valuable information for drug development.


Subject(s)
Diabetes Mellitus, Type 2/enzymology , Insulin/metabolism , Islets of Langerhans/enzymology , Phosphoprotein Phosphatases/physiology , Calcineurin/physiology , Humans , Insulin Secretion , Islets of Langerhans/metabolism , Phosphoproteins/metabolism , Phosphorylation , Protein Phosphatase 2
7.
J Physiol ; 563(Pt 2): 471-82, 2005 Mar 01.
Article in English | MEDLINE | ID: mdl-15649984

ABSTRACT

The initial response of liver cells to insulin is mediated through exocytosis of Cl- channel-containing vesicles and a subsequent opening of plasma membrane Cl- channels. Intracellular accumulation of fatty acids leads to profound defects in metabolism, and is closely associated with insulin resistance. It is not known whether the activity of Cl- channels is altered in insulin resistance and by which mechanisms. We studied the effects of fatty acid accumulation on Cl- channel opening in a model liver cell line. Overnight treatment with amiodarone increased the fat content by approximately 2-fold, and the rates of gluconeogenesis by approximately 5-fold. The ability of insulin to suppress gluconeogenesis was markedly reduced indicating that amiodarone treatment induces insulin resistance. Western blot analysis showed that these cells express the same number of insulin receptors as control cells. However, insulin failed to activate exocytosis and Cl- channel opening. These inhibitory effects were mimicked in control cells by exposures to arachidonic acid (15 microm). Further studies demonstrated that fatty acids stimulate the PKC activity, and inhibition of PKC partially restored exocytosis and Cl- channel opening in insulin-resistant cells. Accordingly, activation of PKC with PMA in control cells potently inhibited the insulin responses. These results suggest that stimulation of PKC activity in insulin resistance contributes to the inhibition of cellular responses to insulin in liver cells.


Subject(s)
Hepatocytes/enzymology , Insulin Resistance/physiology , Insulin/pharmacology , Protein Kinase C/physiology , Amiodarone/pharmacology , Animals , Cell Line, Tumor , Chloride Channels/physiology , Electric Conductivity , Enzyme Inhibitors/pharmacology , Exocytosis/physiology , Fatty Acids/physiology , Hepatocytes/drug effects , Isoenzymes/physiology , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...